NorthRock Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.54M | Buy |
34,953
+2,440
| +8% | +$568K | 0.14% | 92 |
|
|
2025
Q4 | $6.73M | Sell |
32,513
-16,406
| -34% | -$3.24M | 0.11% | 99 |
|
|
2025
Q3 | $9.07M | Buy |
48,919
+3,057
| +7% | +$524K | 0.16% | 72 |
|
|
2025
Q2 | $7.01M | Buy |
45,862
+679
| +2% | +$104K | 0.18% | 53 |
|
|
2025
Q1 | $7.49M | Buy |
45,183
+3,390
| +8% | +$530K | 0.25% | 48 |
|
|
2024
Q4 | $6.04M | Sell |
41,793
-5,366
| -11% | -$832K | 0.2% | 58 |
|
|
2024
Q3 | $7.64M | Buy |
47,159
+401
| +0.9% | +$63.9K | 0.25% | 48 |
|
|
2024
Q2 | $6.83M | Buy |
46,758
+239
| +0.5% | +$35.5K | 0.26% | 52 |
|
|
2024
Q1 | $7.36M | Sell |
46,519
-3,723
| -7% | -$593K | 0.28% | 48 |
|
|
2023
Q4 | $7.87M | Buy |
50,242
+23,768
| +90% | +$3.64M | 0.33% | 44 |
|
|
2023
Q3 | $4.12M | Buy |
26,474
+6,144
| +30% | +$1.01M | 0.43% | 30 |
|
|
2023
Q2 | $3.37M | Sell |
20,330
-3,197
| -14% | -$516K | 0.37% | 32 |
|
|
2023
Q1 | $3.65M | Sell |
23,527
-1,650
| -7% | -$266K | 0.39% | 32 |
|
|
2022
Q4 | $4.45M | Sell |
25,177
-2,210
| -8% | -$382K | 0.51% | 25 |
|
|
2022
Q3 | $4.47M | Sell |
27,387
-3,323
| -11% | -$562K | 0.52% | 26 |
|
|
2022
Q2 | $5.45M | Sell |
30,710
-423
| -1% | -$75.4K | 0.57% | 23 |
|
|
2022
Q1 | $5.52M | Sell |
31,133
-3,824
| -11% | -$651K | 0.5% | 27 |
|
|
2021
Q4 | $5.98M | Buy |
34,957
+2,790
| +9% | +$457K | 0.45% | 27 |
|
|
2021
Q3 | $5.21M | Buy |
32,167
+1,738
| +6% | +$297K | 0.43% | 26 |
|
|
2021
Q2 | $5.01M | Buy |
30,429
+1,168
| +4% | +$193K | 0.42% | 26 |
|
|
2021
Q1 | $4.81M | Buy |
29,261
+782
| +3% | +$127K | 0.44% | 29 |
|
|
2020
Q4 | $4.48M | Sell |
28,479
-958
| -3% | -$141K | 0.44% | 30 |
|
|
2020
Q3 | $4.38M | Buy |
29,437
+730
| +3% | +$108K | 0.49% | 30 |
|
|
2020
Q2 | $4.04M | Buy |
28,707
+40
| +0.1% | +$5.83K | 0.48% | 30 |
|
|
2020
Q1 | $3.76M | Sell |
28,667
-1,997
| -7% | -$283K | 0.53% | 35 |
|
|
2019
Q4 | $4.47M | Buy |
30,664
+6,334
| +26% | +$859K | 0.47% | 41 |
|
|
2019
Q3 | $3.15M | Buy |
24,330
+22,596
| +1,303% | +$2.98M | 0.43% | 51 |
|
|
2019
Q2 | $241K | Buy |
1,734
+13
| +0.8% | +$1.8K | 0.07% | 69 |
|
|
2019
Q1 | $239K | Buy |
+1,721
| New | +$231K | 0.06% | 74 |
|
|
2018
Q1 | – | Sell |
-1,466
| Closed | -$205K | – | 62 |
|
|
2017
Q4 | $205K | Buy |
+1,466
| New | +$204K | 0.07% | 54 |
|
|
2017
Q1 | – | Sell |
-1,766
| Closed | -$203K | – | 47 |
|
|
2016
Q4 | $203K | Hold |
1,766
| – | – | 0.07% | 54 |
|
|
2016
Q3 | $209K | Hold |
1,766
| – | – | 0.09% | 44 |
|
|
2016
Q2 | $214K | Buy |
+1,766
| New | +$201K | 0.1% | 40 |
|
Other funds holding JNJ
VCM
VPM
NorthRock Partners's JNJ Position: Q1 2026 in Review
NorthRock Partners increased its Johnson & Johnson (JNJ) stake by 7.5% in Q1 2026, buying an estimated $568K and bringing the position to 34,953 shares worth $8.54M. The position accounts for 0.14% of the portfolio, ranked #92.
NorthRock Partners first reported a position in JNJ in Q2 2016 and has held it in 33 quarters since. The position peaked at $9.07M in Q3 2025. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- NorthRock Partners held 34,953 shares of Johnson & Johnson worth $8.54M as of Q1 2026.
- NorthRock Partners bought 2,440 Johnson & Johnson shares in Q1 2026, an estimated $568K.
- Johnson & Johnson made up 0.14% of NorthRock Partners's portfolio in Q1 2026, its #92 holding.
- NorthRock Partners first reported a position in Johnson & Johnson in Q2 2016 and has held it in 33 quarters since.
- NorthRock Partners's Johnson & Johnson position peaked at $9.07M in Q3 2025.
- 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on NorthRock Partners's 13F filing for Q1 2026, filed 15 May 2026.